We are live on
!
Find out more
3C
325 Capital Portfolio holdings
AUM
$274M
1-Year Est. Return
49.96%
This Fund
S&P 500
This Quarter
Est. Return
-5.8%
1 Year Est. Return
+49.96%
3 Year Est. Return
+158.78%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.7M
AUM Growth
-$22.1M
(-21%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-13.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
1
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astrana Health
ASTH
|
+$16.4M |
| 2 |
Astronics
ATRO
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDSN
Hudson Technologies
HDSN
|
+$10.3M |
| 2 |
Stride
LRN
|
+$9.47M |
| 3 |
Digi International
DGII
|
+$8.72M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.95% |
| 2 | Industrials | 26.81% |
| 3 | Consumer Discretionary | 18.35% |
| 4 | Healthcare | 16.27% |
| 5 | Consumer Staples | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXGN
1
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $20.3M | 23.64% |
1,144,502
| – | – |
|
2
Motorcar Parts of America
MPAA
$261M
| $15.7M | 18.35% |
1,032,865
| – | – |
|
|
3
Astrana Health
ASTH
$2B
| $13.9M | 16.27% |
+357,407
| New | +$16.4M |
|
|
4
Astronics
ATRO
$3.45B
| $13.1M | 15.27% |
1,998,044
+327,996
| +20% | +$2.74M |
|
5
Blue Bird Corp
BLBD
$2.41B
| $9.89M | 11.54% |
1,184,051
| – | – |
|
6
American Public Education
APEI
$875M
| $8.58M | 10.01% |
938,528
| – | – |
|
7
Transact Technologies
TACT
$51.7M
| $3.69M | 4.31% |
1,011,789
| – | – |
|
|
HDSN
8
Hudson Technologies
HDSN
$267M
| $517K | 0.6% |
70,288
-1,222,503
| -95% | -$10.3M |
|
|
9
Digi International
DGII
$2.52B
| – | – |
-360,231
| Closed | -$8.72M |
|
|
10
iShares Russell 2000 ETF
IWM
$80.9B
| – | – |
-12,655
| Closed | -$2.14M |
|
|
11
Stride
LRN
$3.69B
| – | – |
-232,110
| Closed | -$9.47M |
|
Similar funds
ACM
MP
PP
JWM
REA
OL
HCM
BWM
325 Capital's Q3 2022 Portfolio in Review
As of Q3 2022, 325 Capital held 11 positions worth $85.7M, down 21% from $108M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
325 Capital withdrew a net $11.5M in Q3 2022, closing 3 positions and reducing 1 holding. Its most notable exit was Stride, an estimated $9.47M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, 325 Capital opened a new position in Astrana Health worth $13.9M.
- 325 Capital's largest Q3 2022 buy was Astrana Health: 357,407 shares worth $13.9M.
- 325 Capital added most to Astronics in Q3 2022, an estimated $2.74M increase.
- 325 Capital's biggest Q3 2022 reduction was Hudson Technologies, cutting an estimated $10.3M.
- 325 Capital fully exited Stride in Q3 2022, selling an estimated $9.47M.
- 325 Capital's ten largest holdings make up 100% of its $85.7M portfolio in Q3 2022.
- 325 Capital opened 1 new position and closed 3 in Q3 2022.
- 325 Capital's portfolio value fell 21% quarter-over-quarter to $85.7M.
Based on 325 Capital's 13F filing for Q3 2022, filed 14 Nov 2022.